Business
AI summarySelvita S.A. provides drug discovery, drug development, and contract testing services in Poland. Its capabilities span computer-aided drug design and AI, medicinal and synthetic chemistry, structural biology, in vitro and in vivo testing, ADME and pharmacokinetics, proteomics and other omics services, antibody discovery, and CMC and regulatory support for active substances and drug products. Formerly known as Selvita CRO S.A., it took its current name in 2019; the company was founded in 2007 and is headquartered in Kraków, Poland.
